0001567619-20-006626.txt : 20200317
0001567619-20-006626.hdr.sgml : 20200317
20200317210507
ACCESSION NUMBER: 0001567619-20-006626
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200313
FILED AS OF DATE: 20200317
DATE AS OF CHANGE: 20200317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ajer Jeffrey Robert
CENTRAL INDEX KEY: 0001557533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26727
FILM NUMBER: 20722919
MAIL ADDRESS:
STREET 1: C/O BIOMARIN PHARMACEUTICAL INC.
STREET 2: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC
CENTRAL INDEX KEY: 0001048477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 680397820
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 4155066700
MAIL ADDRESS:
STREET 1: 105 DIGITAL DRIVE
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
doc1.xml
FORM 4
X0306
4
2020-03-13
0
0001048477
BIOMARIN PHARMACEUTICAL INC
BMRN
0001557533
Ajer Jeffrey Robert
C/O BIOMARIN PHARMACEUTICAL INC.,
105 DIGITAL DRIVE
NOVATO
CA
94949
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2020-03-13
4
F
0
7644
84.50
D
63886
D
Common Stock
2020-03-16
4
A
0
10380
0
A
74266
D
Stock Option (Right to buy Common Stock)
73.82
2020-03-16
4
A
0
29590
0
A
2021-03-16
2030-03-15
Common Stock
29590
29590
D
Restricted stock units granted on March 16, 2020. Price not applicable.
Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter.
/s/ Eric Fleekop, Attorney-in-Fact
2020-03-17